Skip to main navigation
Skip to search
Skip to main content
UTMB Health Research Expert Profiles Home
Help & FAQ
Home
Experts
Departments
Equipment
Projects/Grants
Publications
Activities
Press/Media
Honors
Impacts
Search by expertise, name or affiliation
Complement C2 siRNA mediated therapy of myasthenia gravis in mice
Ruksana Huda
, Erdem Tüzün
, Premkumar Christadoss
Microbiology And Immunology
Research output
:
Contribution to journal
›
Article
›
peer-review
40
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Complement C2 siRNA mediated therapy of myasthenia gravis in mice'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acetylcholine Receptor (AChR)
33%
Autoimmune Disease
16%
Blood Cells
16%
Booster Immunization
16%
Cascading Activation
16%
Classical Complement Pathway
16%
Complement C2
100%
Complement Cascade
16%
Complement Component C4
16%
Complement Components
16%
Complement System
16%
Experimental Autoimmune Myasthenia Gravis
100%
Forelimb muscle
16%
IgG2b
16%
Liver
16%
Low Protein
16%
Membrane Attack Complex
16%
Monoclonal Antibody
16%
Muscle Reduction
16%
Muscle Strength
16%
Muscle Weakness
16%
Myasthenia Gravis
100%
Neuromuscular Junction
16%
Remission
16%
Second Booster
16%
Small Interfering RNA (siRNA)
100%
Immunology and Microbiology
Acetylcholine
16%
Autoimmune Disease
16%
Classical Complement Pathway
16%
Complement
16%
Complement Component 2
100%
Complement Component 4
16%
Complement Component C1q
16%
Complement Membrane Attack Complex
16%
Complement System
16%
Experimental Autoimmune Myasthenia Gravis
100%
Immunoglobulin G2b
16%
Monoclonal Antibody
16%
Muscle
50%
Muscle Strength
16%
Myasthenia gravis
100%
Neuromuscular Junction
16%